<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156501">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02027792</url>
  </required_header>
  <id_info>
    <org_study_id>13-5581 KoGon</org_study_id>
    <nct_id>NCT02027792</nct_id>
  </id_info>
  <brief_title>Cabbage Leaf Wraps in Osteoarthritis of the Knee</brief_title>
  <acronym>KoGon</acronym>
  <official_title>Randomised Controlled Trial on the Efficacy of Cabbage Leaf Wraps in Symptomatic Primary Osteoarthritis of the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomised controlled trial aims to investigate the efficacy of cabbage leaf cataplasms
      in the treatment of primary symptomatic osteoarthritis of the knee. 81 patients will be
      randomised into one of 3 groups and apply either cabbage leaf cataplasm or diclofenac gel
      daily for 4 weeks or receive only usual care. Efficacy will be measured using questionnaire
      on pain, disability, quality of life and pressure pain sensitivity.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain intensity measured on three 0-100mm visual analog scales (actual, mean, worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>knee function (WOMAC)</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>physical everyday function using the validated WOMAC questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (SF-36)</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>health related quality of life with the validated SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>self-efficacy (ASES-D)</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>self-efficacy with the arthritis specific self efficacy scale in German</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function (30second chair test)</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>validated test to measure how often patients can stand up from a chair in 30 seconds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure pain sensitivity</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by an algometer at predefined areas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Safety measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>knee function (WOMAC)</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>physical everyday function using the validated WOMAC questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (SF-36)</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>health related quality of life with the validated SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>self-efficacy (ASES-D)</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>self-efficacy with the arthritis specific self efficacy scale in German</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function (30second chair test)</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>validated test to measure how often patients can stand up from a chair in 30 seconds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure pain sensitivity</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by an algometer at predefined areas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Safety measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>pain intensity measured on three 0-100mm visual analog scales (actual, mean, worst pain)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Course of Pain</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measured by a diary including pain intensity on a visual analogue scale, medication</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction</measure>
    <time_frame>20 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Satisfaction with either treatments</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">81</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>Cabbage leaf wraps</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily application of cabbage leaf wraps over night, 4 weeks application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>daily application of diclofenac gel 4 weeks application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no specific intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cabbage leave wraps</intervention_name>
    <arm_group_label>Cabbage leaf wraps</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac Gel</intervention_name>
    <arm_group_label>Diclofenac gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  osteoarthritis of the knee, Kellgren Lawrence stadium 2-3

          -  at least 50% of days with complaints

          -  initial pain intensity 45mm on a 100mm visual analoge scale

        Exclusion Criteria:

          -  medication with corticoids or immunsupressing drugs

          -  secondary arthritis/arthrosis

          -  operation to the knee within 12 months prior

          -  injection within 4 weeks (cortison) or 6 months prior (hyaluronic acid)

          -  severe comorbidities (liver, kidney, asthma, psychiatric disorders etc.)

          -  participation in other studies

          -  pregnancy, breastfeeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Internal and Integrative Medicine, Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>January 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Romy Lauche</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
